MetaVia MTVA
NASDAQ MTVA
$1.46 +0.02 (+1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

MetaVia (MTVA) Other Accumulated Expenses (2018 - 2026)

MetaVia's (MTVA) quarterly Other Accumulated Expenses came in at $149000.0 in Q4 2025, up 170.91% YoY from $55000.0 in Q4 2024, and down 95.51% on a QoQ basis from $3.3 million in Q3 2025.

MetaVia (MTVA) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

MetaVia (MTVA) has 8 years of Other Accumulated Expenses data on file, last reported at $149000.0 in Q4 2025.

  • Quarterly Other Accumulated Expenses rose 170.91% year-over-year to $149000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $149000.0 (up 170.91% YoY) and the FY2025 annual result came in at $149000.0, up 170.91% from the prior year.
  • Other Accumulated Expenses retreated to $149000.0 in Q4 2025, from $3.3 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $3.5 million in Q3 2024 to a low of $12000.0 in Q4 2021.
  • A 5-year average of $592166.7 and a median of $51500.0 in 2022 frame the typical range for Other Accumulated Expenses.
  • Annual changes were most pronounced in 2024 — Other Accumulated Expenses tumbled 93.03% — and 2025, when it surged 3553.85%.
  • Tracing MTVA's Other Accumulated Expenses over 5 years: stood at $12000.0 in 2021, then jumped by 300.0% to $48000.0 in 2022, then jumped by 1543.75% to $789000.0 in 2023, then plunged by 93.03% to $55000.0 in 2024, then jumped by 170.91% to $149000.0 in 2025.
  • The last three Other Accumulated Expenses figures came in at $149000.0 (Q4 2025), $3.3 million (Q3 2025), and $15000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 MetaVia 8.72 Mn -3.92 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 1.90 Mn
Dec 31, 2025 149,000.00
Sep 30, 2025 3.32 Mn
Jun 30, 2025 15,000.00
Mar 31, 2025 2.38 Mn
Dec 31, 2024 55,000.00
Sep 30, 2024 3.50 Mn
Jun 30, 2024 15,000.00
Mar 31, 2024 65,000.00
Dec 31, 2023 789,000.00
Mar 31, 2023 19,000.00
Dec 31, 2022 48,000.00
Sep 30, 2022 94,000.00
Jun 30, 2022 36,000.00
Mar 31, 2022 36,000.00
Dec 31, 2021 12,000.00
Sep 30, 2021 31,000.00
Jun 30, 2021 36,000.00
Mar 31, 2021 68,000.00
Dec 31, 2020 40,000.00